| Stage | NOVT | % of rev | CWST | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $266M | 100.00% | $544M | 100.00% | CWST ×2.05 |
| Gross profit | $121M | 45.49% | $179M | 32.88% | NOVT +12.6pp |
| Operating income | $18M | 6.79% | $20M | 3.67% | NOVT +3.1pp |
| Pre-tax income | $16M | 5.98% | $3M | 0.62% | NOVT +5.4pp |
| Net income | $13M | 4.72% | $4M | 0.69% | NOVT +4.0pp |
| Stage | NOVT | CWST | Gap · A − B |
|---|---|---|---|
| Revenue | $266M100.00% | $544M100.00% | CWST ×2.05 |
| Gross profit | 45.49%$121M | 32.88%$179M | NOVT +12.6pp |
| Operating income | 6.79%$18M | 3.67%$20M | NOVT +3.1pp |
| Pre-tax income | 5.98%$16M | 0.62%$3M | NOVT +5.4pp |
None
No disclosed counterparties: NOVT.
| Net income |
| 4.72%$13M |
| 0.69%$4M |
| NOVT +4.0pp |